| ABCELLERA BIOLOGICS |
| Kanada |
| Gesundheit |
| CA00288U1066 / A2QKXS |
| 8QQ (Frankfurt) / ABCL (NASDAQ) |
| FRA:8QQ, ETR:8QQ, 8QQ:GR, NASDAQ:ABCL |
| - |
| https://www.abcellera.com.. |
|
AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based medicines targeting unmet medical needs in endocrinology, women's health, immunology, and oncology. It employs an advanced antibody discover..
>Volltext.. |
| 1033.37 Mio. EUR |
| 677.81 Mio. EUR |
| 63.86 Mio. EUR |
| -160.05 Mio. EUR |
| -124.46 Mio. EUR |
| -0.42 EUR |
| 121.74 Mio. EUR |
| 131.77 Mio. EUR |
| -111.84 Mio. EUR |
| 8.71 |
| 129.65% |
| 20.76% |
| - |
| - |
| - |
| - |
| ABCELLERA |
| 21.04.26 |
|